Trials / Not Yet Recruiting
Not Yet RecruitingNCT07135973
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
A Multi-center, Single-arm Phase IV Clinical Trial to Evaluate the Safety of Belumosudil in Indian Participants, 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This is an interventional phase IV clinical study which is single-arm study for assessing the safety of belumosudil in Indian patients who are12 years and older. Study details include: * The study duration will be up to 12 months per participant. * The treatment duration will be up to 24 weeks. * The number of visits will be 7.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Belumosudil | Pharmaceutical form:Tablet-Route of administration:Oral |
Timeline
- Start date
- 2026-04-15
- Primary completion
- 2027-08-30
- Completion
- 2028-03-17
- First posted
- 2025-08-22
- Last updated
- 2026-03-03
Source: ClinicalTrials.gov record NCT07135973. Inclusion in this directory is not an endorsement.